Results 271 to 280 of about 156,498 (339)
This study demonstrates that combining liposomal Rhenium‐188 (Lipo‐Re188) with macrophage depletion and anti–PD‐L1 therapy enhances therapeutic efficacy against lung metastatic colon cancer. The triple therapy promotes B cell infiltration, restores T cell function, and suppresses MDSC, creating a tumor‐suppressive immune microenvironment.
Shin‐Yi Liu +3 more
wiley +1 more source
Integrated lipidomics and proteomics analysis in the cardiac surgery-associated acute kidney injury. [PDF]
Zhou F +7 more
europepmc +1 more source
Postprandial effects of dietary phosphatidylcholine on plasma lipoproteins in man
P. Simonsson, Å. Nilsson, B. Åkesson
openalex +1 more source
Anti‐HPV vaccine activists claimed that aluminum (Al) adjuvants in HPV vaccines could cause immune abnormalities, leading to neurological diseases. We evaluated the cytokine and histology profiles following administrations of HPV vaccines and other viral vaccines containing adjuvants.
Reona Shiro +9 more
wiley +1 more source
GLS1‐mediated glutaminolysis supports GSH synthesis in cancer cells. GLS1 KO increases ROS, downregulates GPX4, and upregulates GPX1, making cells more sensitive to ferroptosis. Combining GLS1 or GPX1 inhibitors with a GPX4 inhibitor synergistically suppresses cancer growth.
Changsen Bai +13 more
wiley +1 more source
Ginsenosides Rh2 and Rg3 exert their anti-cancer effects on non-small cell lung cancer by regulating cell autophagy and choline-phosphatidylcholine metabolism. [PDF]
Min Z +5 more
europepmc +1 more source
Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetes
Abstract Aims Patients with type 2 diabetes (T2D) are at an elevated risk of developing metabolic dysfunction‐associated steatotic liver disease (MASLD), with a significant likelihood of progression to advanced liver fibrosis (AF)—a stage linked to adverse outcomes.
Sarah Béland‐Bonenfant +10 more
wiley +1 more source
Efficacy of interventions with live combined <i>Bacillus subtilis</i> and <i>Enterococcus faecium</i> enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trials. [PDF]
Wu Y, Wu H, Yi H.
europepmc +1 more source

